Recodagen Corporation's Series A Round

Recodagen Corporation raised a round of funding on March 13, 2008.

Recodagen Corporation's technology is based upon the discovery of a novel class of disease targets. The first therapeutic indications that the company will pursue are for solid tumors in cancer. Recod…

Articles about Recodagen Corporation's Series A Round: